ImmunoPrecise Antibodies Ltd. (HYFT) — Free Cash Flow Generation Index

Latest as of October 2020: -0.62x

ImmunoPrecise Antibodies Ltd. (HYFT) has a Free Cash Flow Generation Index of -0.62x as of October 2020. Free cash flow of $-274.98K represents -1% of operating cash flow ($440.23K). Explore ImmunoPrecise Antibodies Ltd. capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

-0.62x

Free Cash Flow / Operating CF

Free Cash Flow

$-274.98K

USD

Operating Cash Flow

$440.23K

USD

Capital Expenditures

$715.21K

USD

ImmunoPrecise Antibodies Ltd. Free Cash Flow Generation Index (2016–2016)

Historical FCF Generation Index trend for ImmunoPrecise Antibodies Ltd. across 1 annual periods. For the full cash flow conversion analysis, see ImmunoPrecise Antibodies Ltd. cash flow conversion.

Annual Free Cash Flow Generation for ImmunoPrecise Antibodies Ltd. (2016–2016)

Year-by-year Free Cash Flow Generation Index for ImmunoPrecise Antibodies Ltd.. Check ImmunoPrecise Antibodies Ltd. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year	FCG Index	Free Cash Flow (USD)	Operating CF	Capital Expenditures	YoY Change
2016	0.94x	$266.61K	$284.09K	$17.48K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).